Psychiatry · New York, NY
NPI
1861577298
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
460 W 34th St, 9th Fl
New York, NY, 10001
Phone (212) 273-6519
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$268K
3,495 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kusum Kathpalia prescribed most often to Medicare patients was Risperidone, with 419 prescriptions and refills. In total Kusum Kathpalia wrote 3,495 Medicare prescriptions that cost $268K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Risperidone Generic | 419 | 419 | 31 | $14K |
| Sertraline Hcl Generic | 330 | 364 | 37 | $6,520 |
| Aripiprazole Generic | 325 | 351 | 34 | $48K |
| Mirtazapine Generic | 209 | 225 | 20 | $5,654 |
| Clonazepam Generic | 209 | 211 | 22 | $3,365 |
| Escitalopram Oxalate Generic | 191 | 199 | 18 | $6,782 |
| Olanzapine Generic | 190 | 190 | 17 | $10K |
| Quetiapine Fumarate Er Quetiapine Fumarate | 181 | 189 | 15 | $34K |
| Divalproex Sodium Generic | 137 | 147 | 12 | $7,937 |
| Divalproex Sodium Er Divalproex Sodium | 90 | 98 | Under 11 | $5,202 |
| Lamotrigine Generic | 88 | 88 | Under 11 | $2,423 |
| Lorazepam Generic | 84 | 84 | 14 | $1,244 |
| Fluoxetine Hcl Generic | 68 | 74 | Under 11 | $2,639 |
| Trazodone Hcl Generic | 64 | 64 | Under 11 | $1,152 |
| Duloxetine Hcl Generic | 55 | 55 | Under 11 | $6,744 |
Brand drugs: 70 claims; generic drugs: 3,425 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kusum Kathpalia were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.